content_top
43 companies, 1 interpreter! Insight, foresight
and recommendation 

Biostage (BSTG)

0.32
-0.00
(-1.09%)
Sep 11, 4:00PM EDT
content_middle

Biostage is a biotechnology company developing bioengineered organ implants based on the Company's Cellframe™ technology which combines a proprietary biocompatible scaffold with a patient's own stem cells to create Cellspan organ implants.

Cellspan implants are being developed to treat life-threatening conditions of the esophagus, bronchus or trachea with the hope of dramatically improving the treatment paradigm for patients.

Based on its pre-clinical data, Biostage has selected life-threatening conditions of the esophagus as the initial clinical application of its technology.

Previous Close: 
0.32
Open: 
0.32
Bid: 
0.31
Ask: 
0.34
1yr Target Price: 
3.00
Day's Range: 
0.31 - 0.33
52wk Range: 
0.22 - 1.42
Volume: 
397243
Average Daily Volume: 
1364120
Market Capitalization: 
12.32M
Trailing Annual Dividend Yield: 
N/A
Shares Outstanding: 
38933000M